Simone Jacoby

Global <scp>HIV</scp>‐1 transmitted drug resistance in the <scp>INSIGHT S</scp>trategic <scp>T</scp>iming of <scp>A</scp>nti<scp>R</scp>etroviral <scp>T</scp>reatment (<scp>START</scp>) trial

JD Baxter, David Dunn, Ellen White et al. · HIV Medicine · 2015 · 61 citations · Full text

Public Health, Pharmacology, Hiv Control +16

Immediate Initiation of Antiretroviral Therapy for HIV Infection Accelerates Bone Loss Relative to Deferring Therapy: Findings from the START Bone Mineral Density Substudy, a Randomized Trial

Jennifer Hoy, Birgit Grund, Mollie Roediger et al. · Journal of Bone and Mineral Research · 2017 · 59 citations · Full text

Public Health, Infectious Disease Control, Bone Metabolism +16

Dolutegravir plus boosted darunavir versus recommended standard-of-care antiretroviral regimens in people with HIV-1 for whom recommended first-line non-nucleoside reverse transcriptase inhibitor therapy has failed (D2EFT): an open-label, randomised, phase 3b/4 trial

Gail Matthews, Simone Jacoby, Margaret Borok et al. · The Lancet HIV · 2024 · 31 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +14